However, dopamine can activate the expression of epidermal growth factor receptor (EGFR) and promote the phosphorylation of mitogen-activated protein kinase by binding to the highly expressed dopamine receptor 2 in GBM cells, thereby promoting the progression of GBM. The gene discussed is WNK2; the disease is glioblastoma.